Progesterone is NOT recommended as a sleep aid for men
Progesterone should not be used as a sleep aid in men due to lack of evidence supporting its efficacy for this indication, absence of FDA approval for sleep disorders, and potential safety concerns including cardiovascular risks and hormonal effects.
Evidence Assessment
FDA-Approved Indications
The FDA-approved uses of progesterone are limited to prevention of endometrial hyperplasia in postmenopausal women taking estrogens (200 mg daily at bedtime for 12 days per 28-day cycle) and treatment of secondary amenorrhea (400 mg at bedtime for 10 days) 1. There is no FDA approval for progesterone as a sleep aid in any population, including men.
Clinical Guidelines on Sleep Disorders
Current evidence-based guidelines for chronic insomnia management make no mention of progesterone as a treatment option:
- The American College of Physicians (2016) recommends cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, with pharmacotherapy only after shared decision-making if CBT-I fails 2
- The American Academy of Sleep Medicine (2017) clinical practice guideline does not include progesterone among recommended pharmacologic treatments 3
- Guidelines for sleep disturbance in older adults recommend modafinil, stimulants, or short-acting benzodiazepines/non-benzodiazepines for specific conditions, but not progesterone 4
Research Evidence in Men
While limited research exists on progesterone's effects on sleep in men, the data does not support clinical use:
Single-dose studies show minimal effects:
- One study in 9 healthy men found progesterone (timing not specified) increased non-REM sleep but decreased slow-wave activity, with effects mediated through GABA-active metabolites 5
- Another study showed progesterone 200 mg IM produced only "mild sedative-like effects" with small increases in fatigue and impaired eye pursuit in both men and women 6
Key limitations:
- Studies used single doses in healthy volunteers, not chronic administration for sleep disorders
- Effects were modest and inconsistent
- No clinical trials have evaluated progesterone specifically as a sleep aid in men with insomnia
- One review noted progesterone's potential role in sleep-breathing disorders but provided no evidence for use as a general sleep aid 7
Safety Concerns
The FDA label warns of significant risks that are particularly concerning for off-label use in men 1:
Serious adverse effects include:
- Abnormal blood clotting (stroke, heart attack, pulmonary embolus)
- Cardiovascular risks
- Extreme dizziness and drowsiness (especially during initial therapy)
- Blurred vision, difficulty speaking, difficulty walking
- Risk to fetus (relevant if prescribed to women of childbearing age)
Common side effects:
- Headaches, nausea, vomiting
- Fluid retention
- Mood changes
Hormonal considerations in men: While progesterone is present in men and affects spermiogenesis, testosterone biosynthesis, and CNS function 8, there is insufficient evidence regarding long-term safety of exogenous progesterone administration in men, particularly regarding effects on the reproductive system, cardiovascular health, and metabolic parameters.
Clinical Approach to Sleep Problems in Men
Instead of progesterone, follow evidence-based guidelines:
First-line treatment: CBT-I (strong recommendation, moderate-quality evidence) 2
- Sleep restriction
- Stimulus control
- Cognitive therapy
- Sleep hygiene education
If pharmacotherapy needed after CBT-I failure:
- Short-acting benzodiazepine receptor agonists (zaleplon, zolpidem) for short-term use
- Consider lowest effective dose for shortest duration
- Avoid long-acting benzodiazepines in older adults
Evaluate and treat underlying causes:
- Sleep apnea (especially relevant given progesterone's respiratory effects)
- Depression or anxiety
- Medical conditions
- Medication side effects
Common Pitfalls to Avoid
- Do not prescribe progesterone off-label for sleep based on limited research data or anecdotal reports
- Do not assume effects in postmenopausal women translate to men - most sleep research with progesterone enrolled postmenopausal women 9
- Do not overlook cardiovascular risk assessment before considering any hormonal therapy in men
- Do not use over-the-counter or compounded "bioidentical" progesterone - these lack quality control and evidence
The meta-analysis showing some benefit for sleep onset latency included only postmenopausal women, with most studies confounded by concomitant estradiol use 9. This evidence cannot be extrapolated to men.